Dec 03, 2020 / 06:50PM GMT
Michael Anthony Newshel - Evercore ISI Institutional Equities, Research Division - Associate
So welcome, everyone, to our fireside chat with LabCorp. I'm Mike Newshel. I cover the labs and health care facilities and managed care as well at Evercore ISI. And I'm very pleased to be joined by LabCorp's CEO, Adam Schechter; as well as CFO, Glenn Eisenberg; and we also, I don't know if you can see her, but Clarissa Willett, the VP of Investor Relations, is with us as well. Thanks, guys, for being -- joining us today. Looking forward to getting an update on your business and dig in into some things here.
Questions and Answers:
Michael Anthony Newshel - Evercore ISI Institutional Equities, Research Division - AssociateSo I think we'll start with you. We'll just go right into it -- to Q&A. And I think on a logical place to start is, if you could just give us an update on COVID testing in the Diagnostics business and where things stand now? I know a few weeks ago, ACLA, the industry group, warned about some capacity constraints, again, the longer turnaround